Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections (Sprixx-ICU)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01050608|
Recruitment Status : Completed
First Posted : January 15, 2010
Last Update Posted : June 23, 2011
|Condition or disease||Intervention/treatment|
|Nosocomial Infection||Device: Body worn alcohol gel dispenser Drug: 62% ethanol based hand cleanser Behavioral: Educational component with regard to teaching CDC guidelines Behavioral: Provider and group feedback|
|Study Type :||Observational|
|Actual Enrollment :||2954 participants|
|Official Title:||Real Time Deployment of Multimodal Personal Dispenser Hand Hygiene System in a Multidisciplinary Intensive Care Unit.|
|Study Start Date :||December 2007|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||January 2011|
Sprixx Device Group
Treatment group utilizing multimodal hand hygiene device
Device: Body worn alcohol gel dispenser
Records hand hygiene events of provider and tabulates on the group level.
Drug: 62% ethanol based hand cleanser
CDC based guidelines with regard to utilization in the health care environment "the nest"
Behavioral: Educational component with regard to teaching CDC guidelines
12 minute education prior to deploying device for all providers.
Behavioral: Provider and group feedback
Provide feedback with regard to expected hand hygiene goals to providers and reported anonymous group results based on recorded information.
Standard Hand Hygiene Group
Utilizing wall mounted dispensers and CDC based guidelines.
- Reduction in healthcare associated infections (CRBSI and VAP) [ Time Frame: 2 years ]
- Time to infections Hospital mortality Length of stay [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01050608
|United States, New Hampshire|
|Dartmouth-HItchcock Medical Center|
|Lebanon, New Hampshire, United States, 03756|
|Principal Investigator:||Matthew D. Koff, M.D. M.S.||Dartmouth-Hitchcock Medical Center|
|Principal Investigator:||Randy L Loftus, M.D.||Dartmouth-Hitchcock Medical Center|